These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15585609)

  • 21. Radioimmunotherapy for lymphoma.
    Zelenetz AD
    Curr Opin Oncol; 1999 Sep; 11(5):375-80. PubMed ID: 10505774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against.
    von Schilling C
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1254-6. PubMed ID: 12418478
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa.
    Shome D; Esmaeli B
    Curr Opin Ophthalmol; 2008 Sep; 19(5):414-21. PubMed ID: 18772675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macromolecular approach for targeted radioimmunotherapy in non-Hodgkin's lymphoma.
    Hee C; Ho D; Karton A; Nealon G; Kretzmann JA; Norret M; Iyer KS
    Chem Commun (Camb); 2019 Nov; 55(96):14506-14509. PubMed ID: 31735949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
    Long J; Versea L
    Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2006 Nov; 91(11):1453-5. PubMed ID: 17082005
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody.
    Decaudin D; Levy R; Lokiec F; Morschhauser F; Djeridane M; Kadouche J; Pecking A
    Anticancer Drugs; 2007 Jul; 18(6):725-31. PubMed ID: 17762404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
    Maloney DG
    J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
    Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of primary non-Hodgkin's lymphoma of the vulva with radiation therapy.
    Tokatli F; F Oz-Puyan F; Alas R; Usta U; Yilmaz H; Uzal C
    J BUON; 2009; 14(1):119-22. PubMed ID: 19365881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphoma.
    Martin P; Furman RR; Coleman M; Leonard JP
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5636s-5642s. PubMed ID: 17875800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
    Nowakowski GS; Witzig TE
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):225-31. PubMed ID: 16728934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging radiolabeled therapies hold promise for treatment of cancer.
    Kotz D
    J Nucl Med; 1997 Oct; 38(10):19N, 23N, 39N. PubMed ID: 9379220
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of local infiltration of a heterologous antiserum of lymphoma cutis in man.
    GRACE JT; GOLLAN F; TAYLOR WL; CARLSON RI
    Surg Forum; 1957; 8():185-7. PubMed ID: 13529581
    [No Abstract]   [Full Text] [Related]  

  • 38. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Friedberg JW
    Clin Cancer Res; 2004 Dec; 10(23):7789-91. PubMed ID: 15585609
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosimetry and radioimmunotherapy of non-Hodgkin's lymphoma.
    Postema EJ
    J Nucl Med; 2004 Dec; 45(12):2126-7; author reply 2127. PubMed ID: 15585492
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    Whelton S
    Nurse Pract; 2007 Dec; 32(12):35-8. PubMed ID: 18043410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.